DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.

ABSTRACT:

SUBMITTER: Kizhakeyil A 

PROVIDER: S-EPMC8520256 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature